Ella Tablet
Product Images NDC 73302-456

4 FDA label images from Pmi Branded Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ella (NDC 73302-456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pmi Branded Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Label (Blister)

Blister Label (Blister)
The image shows a label for Ella ulipristal acetate tablet 30 mg. It indicates the packaging contains one 30 mg tablet. The label includes instructions to push through from the front and lists the manufacturer as HRA Pharma America Inc., located in Morristown, NJ. The label also shows the NDC number 73302-456-01.*
FDA Label Image

Carton (Carton)

Carton (Carton)
Packaging label for Ella ulipristal acetate 30 mg oral tablet. The label shows the product name, dosage strength, and quantity as one tablet per package. It also displays the NDC number 73302-456-01 and indicates the labeler as PMI Branded Pharmaceuticals, Inc. Additional storage and usage instructions are included on the label.*
FDA Label Image

Ulipristal Acetate Structural Formula (Ella Tablet 1)

Ulipristal Acetate Structural Formula (Ella Tablet 1)
Chemical structure diagram of ulipristal acetate, the active ingredient in Ella 30 mg oral tablets by PMI Branded Pharmaceuticals, Inc. The structure shows the arrangement of atoms and bonds characterizing this compound.*
FDA Label Image

Figure 1 (Figure1color)

Figure 1 (Figure1color)
A pharmacokinetic concentration-time graph showing levels of ulipristal acetate and its metabolite monodemethyl-ulipristal acetate in ng/mL over a 168-hour period. Concentrations for both compounds decline over time, with ulipristal acetate levels consistently higher than the metabolite. The y-axis is logarithmic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.